Results of a phase three clinical trial of a novel brain cancer vaccine, DCVax-L, that uses a patient's stem cells to target cancer cells extend survival by many months to years for glioblastoma patients.
Brain Cancer
Brain Cancer research articles are listed. Brain cancer news covers topics such as diagnosis, brain tumors, chemotherapy, gamma knife technology, brain cancer treatments, glioblastomas, stem cell research, neurosurgery, medicine, genetics, neurology, and other brain research.
Analyzing networks within the brain can help researchers determine the risks for aphasia when deciding to operate to remove brain tumors.
A new implantable pump system safely and effectively bypasses the blood-brain barrier to deliver chemotherapy drugs to those with glioblastoma brain cancer.
Aerobic exercise reduces the risk of metastatic cancer by elevating glucose consumption.
The commercial dietary supplement nicotinamide riboside, touted to improve cardiovascular and neurological health, may actually increase the risk of developing breast cancer that metastasizes to the brain.
Individuals with a rare type of breast cancer called inflammatory breast cancer are at greater risk of their cancer spreading to the brain.
Higher levels of the inflammatory C-reactive protein were discovered in older breast cancer survivors who experienced cognitive issues. The study is one of the first long-term assessments linking chronic inflammation to cognitive decline in breast cancer survivors.
Researchers study the effect of letrozole , a drug designed for the treatment of breast cancer in postmenopausal women, on glioblastoma brain cancer.
Using gene editing to boost the production of SOD3 in the choroid plexus reduced oxidative damage to brain tissue and cerebral spinal fluid in mice exposed to methotrexate.
Study reveals a moderate link between antipsychotic use and an increased risk of developing breast cancer.
Sufferers of obstructive sleep apnea are at increased risk of developing cancer and thrombosis. In those over 74, OSA was associated with an increased risk of cognitive decline.
Researchers have uncovered the molecular mechanisms behind cognitive deficits and brain fog associated with chemotherapy, and identified a current FDA-approved drug for multiple sclerosis that can help reduce chemotherapy-induced cognitive impairments.
